ImmunoPrecise Antibodies Ltd (IPA)
0.461
-0.02
(-3.42%)
USD |
NASDAQ |
Nov 14, 12:20
ImmunoPrecise Antibodies Price to Book Value: 0.5425 for Nov. 14, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 0.5617 |
| November 12, 2024 | 0.5532 |
| November 11, 2024 | 0.5269 |
| November 08, 2024 | 0.5178 |
| November 07, 2024 | 0.5178 |
| November 06, 2024 | 0.4629 |
| November 05, 2024 | 0.4962 |
| November 04, 2024 | 0.5061 |
| November 01, 2024 | 0.4914 |
| October 31, 2024 | 0.5614 |
| October 30, 2024 | 0.5732 |
| October 29, 2024 | 0.6373 |
| October 28, 2024 | 0.6777 |
| October 25, 2024 | 0.7981 |
| October 24, 2024 | 0.6767 |
| October 23, 2024 | 0.6302 |
| October 22, 2024 | 0.5969 |
| October 21, 2024 | 0.6299 |
| October 18, 2024 | 0.6355 |
| October 17, 2024 | 0.6344 |
| October 16, 2024 | 0.6604 |
| October 15, 2024 | 0.6708 |
| October 14, 2024 | 0.6786 |
| October 11, 2024 | 0.692 |
| October 10, 2024 | 0.6944 |
| Date | Value |
|---|---|
| October 09, 2024 | 0.6956 |
| October 08, 2024 | 0.7398 |
| October 07, 2024 | 0.7297 |
| October 04, 2024 | 0.7356 |
| October 03, 2024 | 0.6385 |
| October 02, 2024 | 0.6858 |
| October 01, 2024 | 0.6879 |
| September 30, 2024 | 0.7521 |
| September 27, 2024 | 0.7621 |
| September 26, 2024 | 0.7884 |
| September 25, 2024 | 0.8003 |
| September 24, 2024 | 0.7615 |
| September 23, 2024 | 0.7562 |
| September 20, 2024 | 0.7885 |
| September 19, 2024 | 0.7944 |
| September 18, 2024 | 0.7768 |
| September 17, 2024 | 0.6814 |
| September 16, 2024 | 0.6378 |
| September 13, 2024 | 0.7885 |
| September 12, 2024 | 0.7367 |
| September 11, 2024 | 0.7309 |
| September 10, 2024 | 0.7549 |
| September 09, 2024 | 0.749 |
| September 06, 2024 | 0.7706 |
| September 05, 2024 | 0.7716 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.4629
Minimum
Nov 06 2024
13.47
Maximum
Dec 29 2020
3.219
Average
2.561
Median
Jan 24 2023
Price to Book Value Benchmarks
| Aurinia Pharmaceuticals Inc | 3.054 |
| Edesa Biotech Inc | 2.730 |
| Lexaria Bioscience Corp | 3.389 |
| Xenon Pharmaceuticals Inc | 3.791 |
| ESSA Pharma Inc | 0.6266 |
Price to Book Value Related Metrics
| PS Ratio | 0.6800 |
| PEG Ratio | -0.0240 |
| Price | 0.461 |
| Earnings Yield | -169.3% |
| Market Cap | 12.87M |
| PEGY Ratio | -0.0240 |